Biotech · Private company
HepQuant, LLC
Track this companyFree. Adds HepQuant, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- HepQuant SHUNT Liver Diagnostic KitPhase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- GS-4997Phase 1 · Severe Alcoholic HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- HepQuant SHUNT TestPhase 1 · Severe Alcoholic HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- PrednisolonePhase 1 · Severe Alcoholic HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- Cholate-24-13C (IND 65121) & Cholate-2,2,4,4-d4 (IND 65123)Hepatitis C, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- Dual cholate clearance assayFontanClinicalTrials.gov · fetched Nov 12, 2026
- HepQuant DuO TestAlcoholic HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- HepQuant SHUNT Liver Diagnostic TestChronic Liver DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MRIFontanClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Cholate Clearance in Fontan and Heart FailureRECRUITING · started Aug 4, 2025ClinicalTrials.gov NCT07009132 · fetched Nov 12, 2026
- HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerNA · RECRUITING · started Jul 16, 2025ClinicalTrials.gov NCT06899152 · fetched Nov 12, 2026
- Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver DiseaseRECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT07060547 · fetched Nov 12, 2026
- HepQuant to Predict Hepatic Encephalopathy After TIPSNA · WITHDRAWN · started Feb 25, 2020ClinicalTrials.gov NCT04664621 · fetched Nov 12, 2026
- The SHUNT-V Study for VaricesNA · COMPLETED · started Jan 23, 2019ClinicalTrials.gov NCT03583996 · fetched Nov 12, 2026
- The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and PhysiologyPHASE2 · TERMINATED · started Dec 8, 2017ClinicalTrials.gov NCT03294941 · fetched Nov 12, 2026
- Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124EARLY_PHASE1 · WITHDRAWN · started Jul 31, 2016ClinicalTrials.gov NCT03087968 · fetched Nov 12, 2026
- Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal CirculationNA · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01579162 · fetched Nov 12, 2026